National Center for Ethics in Health Care
SoundEthics in Health Care
Urine Drug Testing in the Context of Long-Term Opioid Therapy for Pain (5:42)
VHA Handbook 1004.01 requires that providers obtain and document oral informed consent for tests that are “particularly sensitive and may have consequences that the patient might reasonably want to avoid,” including tests used to identify illicit drug use. This podcast discusses the informed consent requirements for urine drug testing (UDT) in the context of long-term opioid therapy for pain.
Play Podcast Now. To save the podcast to your computer, right-click on link
and "Save Target As . . ."
- Identify the type of informed consent required for UDT
- Discuss the ethical basis for informed consent for UDT
- Describe when informed consent for UDT must be obtained
- Describe how to document informed consent for UDT
Discuss strategies for obtaining informed consent for UDT
- VHA Directive 1005: Informed Consent for Long-Term Opioid Therapy for Pain
- VHA Handbook 1004.01: Informed Consent for Clinical Treatments and Procedures
- Frequently Asked Questions: VHA Directive 1005: Informed Consent for Long-Term Opioid Therapy for Pain
Sound Ethics in Health Care theme music copyright Don Taylor Music© 2002-2010